FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Fakultät
German Cancer Research Center
Heidelberg, AlemaniaPublikationen in Zusammenarbeit mit Forschern von German Cancer Research Center (5)
2023
2022
2021
2019
-
IMpassion132 Phase III trial: Atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer
Future Oncology, Vol. 15, Núm. 17, pp. 1951-1961